Funding for this research was provided by:
National Institutes of Health (MH094694)
Ontario Brain Institute
Canadian Institutes of Health Research
Ontario Mental Health Foundation
Received: 12 December 2017
Accepted: 21 March 2018
First Online: 10 April 2018
Ethics approval and consent to participate
: The animal care committees at Vanderbilt University and the Toronto Centre for Phenogenomics approved all these experiments.
: Not applicable
: JV has received research funding from Seaside Therapeutics, Novartis, Roche Pharmaceuticals, Forest, Sunovion, and SynapDx and has consulted for or served on advisory boards for Novartis, Roche, and SynapDx. The remaining authors declare no conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.